Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 4, 2006, Pages 449-457

  Chung, Hye J ^a   Choi, Young H ^a   Kim, So H ^b   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

^b Gangneung Wonju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ACETONITRILE; CYTOCHROME P450 1A2; CYTOCHROME P450 2C11; CYTOCHROME P450 2D1; CYTOCHROME P450 3A2; DEXAMETHASONE SODIUM PHOSPHATE; ENZYME INDUCING AGENT; ENZYME INHIBITOR; FURAFYLLINE; IPRIFLAVONE; ISONIAZID; ORPHENADRINE CITRATE; PHENOBARBITAL; PROADIFEN; QUININE; SULFAPHENAZOLE; TESTOSTERONE; TROLEANDOMYCIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG URINE LEVEL; ENZYME INDUCTION; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; MEASUREMENT; MICHAELIS CONSTANT; NONHUMAN; POWDER; RAT; TABLET;

ANIMALS; ENZYME INDUCTION; ENZYME INHIBITORS; INJECTIONS, INTRAVENOUS; ISOFLAVONES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33645569435     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.4.0004     Document Type: Article

References (48)

1. Arlotto, M. P., Sonderfan, A. J., Klaassen, C. D., Parkinson, A. (1987) Studies on the pregnenolone-16 alpha-carbonitrile-inducible form of rat liver microsomal cytochrome P-450 and UDP-glucuronosyltransferase. Biochem. Pharmacol. 36: 3859-3866
2. Bae, S. K., Lee, D. Y., Lee, A. K., Kwon, J. W., Lee, I., Chung, S.-J., Kim, S. G., Shim, C.-K., Lee, M. G. (2004) Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein-calorie malnutrition. J. Pharm. Sci. 93: 2388-2398
3. Bae, S. K., Lee, S. J., Kim, Y. H., Kim, T., Lee, M. G. (2005) Effects of enzyme inducers or inhibitors on the pharmacokinetics of intravenous oltipraz in rats. J. Pharm. Pharmacol. 57: 443-452
4. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254
5. Brandi, M. L. (1992) Flavonoids: biochemical effects and therapeutic applications. Bone Miner. 19 (suppl. 1): S3-S14
6. Chiou, W. L. (1978) Critical evaluation of the potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J. Pharmacokinet. Biopharm. 6: 539-546
7. Chiou, W. L. (1979) New calculation method for mean apparent drug volume of distribution and application to rational dosage regimens. J. Pharm. Sci. 68: 1067-1069
8. Chiou, W. L. (1980) New calculation method of mean total body clearance of drugs and its application to dosage regimens. J. Pharm. Sci. 69: 90-91
9. Chiou, W. L., Nation, R. L., Peng, G. W., Huang, S. M. (1978) Improved micro-scale high-pressure liquid-chromatographic assay of gentamicin in plasma. Clin. Chem. 24: 1846-1847
10. Cho, M. K., Kim, Y. G., Lee, M. G., Kim, S. G. (1999) Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: complete or partial restoration by cysteine or methionine supplementation. Arch. Biochem. Biophys. 372: 150-158
11. Choi, Y. M., Kim, S. H., Lee, M. G. (1991) Effects of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics and pharmacodynamics of furosemide in rats. J. Pharm. Sci. 80: 638-642
12. Conney, A. H. (1971) Environmental factors influencing drug metabolism. In: La Du, B. N., Mandel, H. G., Way, E. L. (eds) Fundamentals of drug metabolism and drug disposition. Williams & Wilkins, Baltimore, p. 269
13. Correia, M. A. (1995) Appendix B. Rat and human liver cytochromes P450. Substrate and inhibitor specificities and functional markers. In: Oritz de Montellano, P. R. (ed.) Cytochrome P450. Structure, mechanism, and biochemistry. 2nd edn, Plenum Press, New York and London, pp 607-630
14. Duggleby, R. G. (1995) Analysis of enzyme progress curves by nonlinear regression. Methods Enzymol. 249: 61-90
15. Eatman, F. B., Colburn, W. A., Boxenbaum, H. G., Posmanter, H. N., Weinfeld, R. E., Ronfeld, R., Weissman, L., Moore, J. D., Gibaldi, M., Kaplan, S. A. (1977) Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects. J. Pharmacokinet. Biopharm. 5: 481-494
16. Fontana, R. J., Lown, K. S., Paine, M. F., Fortlage, L., Santella, R. M., Felton, J. S., Knize, M. G., Greenberg, A., Watkins, P. B. (1999) Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology 117: 89-98
17. Gibaldi, M., Perrier, D. (1982) Pharmacokinetics. 2nd edn, Marcel-Dekker, New York
18. Halpert, J. R. (1988) Multiplicity of steroid-inducible cytochromes P-450 in rat liver microsomes. Arch. Biochem. Biophys. 263: 59-68
19. Hammond, A. H., Fry, J. R. (1997) Involvement of cytochrome P450 2E1 in the toxicity of dichloropropanol to rat hepatocyte cultures. Toxicology 118: 171-179
20. Kakai, Y., Kawase, T., Nakano, T., Mikuni-Takagaki, Y., Saito, S. (1992) Effect of ipriflavone and estrogen on the differentiation and proliferation of osteogenic cells. Calcif. Tissue Int. 51 (suppl. 1): S11-S15
21. Kawamura, A., Yoshida, Y., Kimura, N., Oda, H., Kakinuma, A. (1999) Phosphorylation/dephosphorylation steps are crucial for the induction of CYP2B1 and CYP2B2 gene expression by phenobarbital. Biochem. Biophys. Res. Commun. 264: 530-536
22. Kim, S. H., Lee, M. G. (2002) Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects. Life Sci. 70: 1299-1315
23. Kim, S. H., Choi, Y. M., Lee, M. G. (1993) Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J. Pharmacokinet. Biopharm. 21: 1-17
24. Kim, S. H., Lee, J. S., Lee, M. G. (1997) Determination of a isoflavone derivative, ipriflavone, and its metabolites, M1 and M5, in rat plasma, urine, and tissue homogenate by high-performance liquid chromatography. Res. Commun. Mol. Pathol. Pharmacol. 98: 313-324
25. Kim, S. H., Lee, J. S., Lee, M. G. (1999) Stability, blood partition and plasma protein binding of ipriflavone, an isoflavone derivative. Biopharm. Drug Dispos. 20: 355-360
26. Kim, E. J., Lee, A. K., Kim, S. H., Kim, S. G., Lee, M. G. (2003) Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagase analbuminemic rats. Drug Metab. Dispos. 31: 194-201
27. Kim, Y. C., Lee, A. K., Lee, J. H., Lee, I., Lee, D. C., Kim, S. H., Kim, S. G., Lee, M. G. (2005) Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation. Eur. J. Pharm. Sci. 26: 114-123
28. Levai, F., Szatmari, I. (1995) Metabolism of ipriflavone. Acta Pharm. Hung. 65: 215-218
29. Levin, W., Thomas, P. E., Ryan, D. E., Wood, A. W. (1987) Isozyme specificity of testosterone 7 alpha-hydroxylation in rat hepatic microsomes: is cytochrome P-450A the sole catalyst? Arch. Biochem. Biophys. 258: 630-635
30. Lewis, D. F. V. (1996) Endogenous steroid hydroxylation by hepatic P450s of families. CYP1, CYP2, and CYP3. In: Lewis, D. F. V. (ed) Cytochromes P450. Structure, function and mechanism. Taylor & Francis, Bristol, p. 123
31. Moon, Y. J., Lee, A. K., Chung, H. C., Kim, E. J., Kim, S. H., Lee, D. C., Lee, I., Kim, S. G., Lee, M. G. (2003) Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats. Drug Metab. Dispos. 31: 776-784
32. Murray, M., Fiala-Beer, E., Sutton, D. (2003) Upregulation of cytochromes P450 2B in rat liver by orphenadrine. Br. J. Pharmacol. 139: 787-796
33. Nishikawa, M., Ariyoshi, N., Kotani, A., Ishii, I., Nakamura, H., Nakasa, H., Ida, M., Nakamura, H., Kimura, N., Kimura, M., Hasegawa, A., Kusu, F., Ohmori, S., Nakazawa, K., Kitada, M. (2004) Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab. Pharmacokinet. 19: 280-289
34. Ogiso, T., Iwaki, M., Tanaka, H., Kobayashi, E., Tanino, T., Sawada, A., Uno, S. (1999) Pharmacokinetic drug interactions between ampiroxicam and sulfaphenazole in rats. Biol. Pharm. Bull. 22: 191-196
35. Pan, L., Belpaire, F. M. (1999) In-vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol. Eur. J. Clin. Pharmacol. 55: 599-604
36. Parkinson, A. (1996) Unit 2. Disposition of toxicants. 6. Biotransformation of xenobiotics. In: Klassen, C. D., Amdur, M. O., Doull, J. (eds) Casarett & Doull's toxicology. The basic science of poisons. 5th edn, McGraw-Hill, Health Professions Division, New York, pp 152-153
37. Reginster, J. Y. (1993) Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis. Bone Miner. 23: 223-232
38. Rohatagi, S., Barrett, J. S. (1997) Integrated pharmacokinetic and metabolic modeling of ipriflavone and metabolites after oral administration. Am. J. Ther. 4: 189-198
39. Rohatagi, S., Barrett, J. S., Sawyers, W., Yu, K., Morales, R. J. (1997) Pharmacokinetics of ipriflavone and metabolites after oral administration of a corn-oil suspension relative to the Osteofix tablet. Am. J. Ther. 4: 229-238
40. Rondelli, I., Acerbi, D., Ventura, P. (1991) Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure. Int. J. Clin. Pharmacol. Res. 11: 183-192
41. Ryan, D. E., Ramanathan, L., Iida, S., Thomas, P. E., Haniu, M., Shively, J. E., Lieber, C. S., Levin, W. (1985) Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid. J. Biol. Chem. 260: 6385-6393
42. Shino, M. (1985) Pharmacokinetic study of ipriflavone (TC-80) by oral administration in healthy male volunteers. Jpn Pharmacol. Ther. 13: 7223-7233
43. Sinclair, J. F., Szakacs, J. G., Wood, S. G., Kostrubsky, V. E., Jeffery, E. H., Wrighton, S. A., Bement, W. J., Wright, D., Sinclair, P. R. (2000) Acetaminophen hepatotoxicity precipitated by short-term treatment of rats with ethanol and isopentanol: protection by triacetyloleandomycin. Biochem. Pharmacol. 59: 445-454
44. Spatzenegger, M., Horsmans, Y., Verbeeck, R. K. (2000) Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats. Pharmacol. Toxicol. 86: 71-77
45. Tomkins, D. M., Otton, S. V., Joharchi, N., Li, N. Y., Balster, R. F., Tyndale, R. F., Sellers, E. M. (1997) Effect of cytochrome P450 2D1 inhibition on hydrocodone metabolism and its behavioral consequences in rats. J. Pharmacol. Exp. Ther. 280: 1374-1382
46. Tyndale, R. F., Li, Y., Li, N. Y., Messina, E., Miksys, S., Sellers, E. M. (1999) Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan. Drug Metab. Dispos. 27: 924-930
47. Williams, J. F., Lowitt, S., Szentivanyi, A. (1979) Effects of phenobarbital and 3-methylcholanthrene pretreatment on the plasma half-life and urinary excretion profile of theophylline and its metabolites in rats. Biochem. Pharmacol. 28: 2935-2940
48. Wrighton, S. A., Maurel, P., Schuetz, E. G., Watkins, P. B., Young, B., Guzelian, P. S. (1985) Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450. Biochemistry 24:2171-2178